U.S. Banks Stock News

NYSE:AMG
NYSE:AMGCapital Markets

Is It Too Late To Consider Affiliated Managers Group (AMG) After Its 79% One Year Run?

Investors may be wondering whether Affiliated Managers Group at around US$286.48 is still offering value, or if most of the easy gains are already on the table. The stock has moved 4.7% over the last 7 days and 1.8% over the last 30 days, with a 79.3% return over 1 year, 106.1% over 3 years and 83.0% over 5 years, even though the year to date return sits at a slight 0.8% decline. Recent coverage has focused on how asset managers are positioning for changing investor preferences and capital...
NYSE:AWR
NYSE:AWRWater Utilities

Is It Too Late To Consider American States Water (AWR) After Recent Share Price Strength?

If you are wondering whether American States Water at around US$77.09 is offering good value right now, it helps to separate the story from the numbers before making any decisions. The stock has posted returns of 1.2% over the last 7 days, 1.9% over 30 days, 6.7% year to date, 5.4% over 1 year, an 11.3% decline over 3 years and 7.9% over 5 years, which gives you a mixed picture of recent and longer term performance. Recent coverage around American States Water has focused on it as a...
NasdaqGS:WEN
NasdaqGS:WENHospitality

Is It Time To Rethink Wendy's (WEN) After A 43% One-Year Share Price Slide?

If you are wondering whether Wendy's current share price really reflects what the business is worth, this breakdown will help you connect the recent moves in the stock to what the underlying valuation signals are saying. The share price recently closed at US$7.06, with returns of 2.3% over 7 days, a 2.9% decline over 30 days, a 13.6% decline year to date, and a 42.8% decline over the past year, which may have shifted how investors view both risk and potential upside. Recent coverage around...
NYSE:FR
NYSE:FRIndustrial REITs

Activist Pressure Tests First Industrial Realty Trust Governance And Valuation Story

Land & Buildings has escalated its activist campaign at First Industrial Realty Trust (NYSE:FR), urging shareholders to vote against the re-election of the current Chairman and a long-serving director at the upcoming annual meeting. The activist investor argues that recent actions by FR, including a share buyback, dividend increase, and addition of a new director, do not fully address what it views as ongoing governance and valuation concerns. Land & Buildings is calling for substantial...
NasdaqGS:PTC
NasdaqGS:PTCSoftware

Is It Time To Reassess PTC (PTC) After Recent Share Price Weakness

Wondering whether PTC at around US$144 per share offers real value or just noise? This article walks through what the current price may be implying about the business. The stock is up 1.3% over the last 7 days, even though it shows a 11.7% decline over 30 days and a 15.2% decline year to date, with a 3.3% decline over the past year and a 14.2% return over three years. These mixed returns put extra focus on what has been moving sentiment around PTC recently, as investors react to new...
NYSE:SPCE
NYSE:SPCEAerospace & Defense

Virgin Galactic (SPCE) Is Up 23.8% After Reopening $750k Flights And Advancing Delta-Class Testing – Has The Bull Case Changed?

Virgin Galactic Holdings recently filed a US$1.35 million shelf registration for 555,000 shares tied to its employee stock plan and reported fourth-quarter 2025 sales of US$312,000 alongside a net loss of US$62.72 million. At the same time, the company has reopened US$750,000-per-seat ticket sales and advanced its Delta-class spacecraft toward testing, highlighting a push to align capital, talent and product readiness ahead of a planned return to commercial service. We’ll now examine how the...
NYSE:MAA
NYSE:MAAResidential REITs

A Look At Mid-America Apartment Communities (MAA) Valuation As Analysts Update Views And Earnings Approach

Mid-America Apartment Communities (MAA) is back in focus as analysts update their views, the REIT prepares to report upcoming earnings, and insiders execute planned share sales alongside a recently confirmed quarterly dividend. See our latest analysis for Mid-America Apartment Communities. The recent 1-day share price return of 1.44% and 7-day gain of 2.89% to US$126.09 sit against a weaker backdrop, with a 30-day share price return of 4.58% and a 1-year total shareholder return of 16.66%...
NasdaqGM:KRUS
NasdaqGM:KRUSHospitality

Kura Sushi USA (KRUS) Same Restaurant Sales Rebound Tests Bullish Growth Narrative

Kura Sushi USA (KRUS) opened Q2 2026 with revenue of US$80.0 million, a basic EPS loss of US$0.14, and net income loss of US$1.7 million, setting the tone for another quarter where top line growth is front and center while profitability remains under pressure. The company has reported quarterly revenue increasing from US$64.9 million in Q2 2025 to US$80.0 million in Q2 2026, while basic EPS moved from a loss of US$0.31 to a loss of US$0.14 over the same period, alongside a trailing twelve...
NasdaqGS:ONC
NasdaqGS:ONCBiotechs

Should FDA Orphan Drug Nod And Analyst Shifts Require Action From BeOne Medicines (ONC) Investors?

BeOne Medicines recently received FDA Orphan Drug Designation for its lead hepatocellular carcinoma candidate, while research firms initiated and adjusted coverage highlighting its broad oncology program and flagship therapy Brukinsa. This combination of regulatory recognition and shifting analyst views underscores how expectations for BeOne’s pipeline and commercialization efforts are being actively reassessed by the market. Next, we’ll examine how the new FDA Orphan Drug Designation could...
NasdaqGS:FRMI
NasdaqGS:FRMISpecialized REITs

The Tactical Trio AI Infrastructure Blueprint One Is Pre Revenue Power One Is P/E Outlier One Is Growth Stage

AI runs on real world hardware, and right now that physical backbone is where a lot of the attention is going. While energy prices, interest rate expectations, and geopolitical tensions are keeping many sectors on edge, the companies building data centers, power connections, and cooling systems are dealing in tangible demand. The AI Infrastructure Stocks screener focuses on those providers that are turning sales into cash flow, instead of just selling a story. In this article, you will see 3...
NYSE:TBBB
NYSE:TBBBConsumer Retailing

BBB Foods (TBBB) Is Up 6.2% After Hedge Funds Back Aggressive 2025 Store Expansion - Has The Bull Case Changed?

In recent months, hedge funds such as Duquesne Capital have been increasing their positions in BBB Foods Inc. (NYSE:TBBB), while the company has expanded its Mexican grocery footprint by opening 574 net new stores during 2025. This combination of rising institutional ownership and rapid store rollout highlights how investors are focusing on BBB Foods’ potential to win customers from traditional mom-and-pop retailers through scale and private-label offerings. Next, we will examine how BBB...
NasdaqGS:NTAP
NasdaqGS:NTAPTech

NetApp Nutanix Alliance Puts Hybrid Cloud And AI Goals In Focus

NetApp (NasdaqGS:NTAP) and Nutanix have announced a new alliance to combine NetApp's Intelligent Data Infrastructure with the Nutanix Cloud Platform and hypervisor. The joint offering is designed for hybrid and multicloud environments, with capabilities for streamlined migration, simplified operations, VM level management, and built in cyber resilience. NetApp and Nutanix also plan deeper integration over time to support customers that are pursuing AI related use cases. For investors...
NasdaqGS:META
NasdaqGS:METAInteractive Media and Services

Meta Platforms And 2 More Founder Led Stocks With Untold Growth Stories

Markets are being pulled in different directions by energy prices, interest rate expectations, and shifting inflation trends, and that can make it harder to know where to focus. One clear anchor is leadership that is deeply invested in its own business. Founder led companies, where leaders typically hold meaningful stakes and think in decades rather than quarters, can offer a different quality of commitment. This article looks at our Top Founder Led Companies screener and highlights three...
NasdaqGM:NRIX
NasdaqGM:NRIXBiotechs

Nurix Therapeutics (NRIX) Heavy Q1 Net Loss Reinforces Bearish Narrative On Profitability

Nurix Therapeutics (NRIX) opened 2026 with Q1 revenue of US$6.3 million and a basic EPS loss of US$0.79, while trailing twelve month figures show revenue of US$71.8 million against a basic EPS loss of US$3.17, framing a business that is still firmly in investment mode. Over the past year, the company has seen quarterly revenue range from US$6.3 million to US$44.1 million and basic EPS move between a loss of US$0.52 and a loss of US$1.03, giving investors a clear view of how top line progress...
NasdaqGS:KNSA
NasdaqGS:KNSABiotechs

Kiniksa’s Heart’s Home Campaign Targets ARCALYST Growth In Pericarditis Market

Kiniksa Pharmaceuticals International (NasdaqGS:KNSA) has launched Heart’s Home, a Direct-to-Consumer campaign focused on ARCALYST for recurrent pericarditis. The campaign aims to expand awareness and empower patients about the only FDA approved therapy for recurrent pericarditis. Heart’s Home represents a new commercial effort to reach patients directly outside the traditional physician focused model. Kiniksa Pharmaceuticals International, listed on NasdaqGS:KNSA, develops and...
NasdaqGS:BOKF
NasdaqGS:BOKFBanks

BOK Financial Leadership Shift Puts Focus On Specialized Industries Risk Profile

BOK Financial (NasdaqGS:BOKF) has promoted Scott Andrews to lead its Specialized Industries Banking group. The appointment follows the planned retirement of Executive Vice President Brad Vincent. The transition affects key lines of business including commercial real estate, energy, and healthcare banking. BOK Financial’s Specialized Industries Banking unit sits at the core of its commercial franchise, with exposure to sectors that tend to be closely watched by lenders and regulators. Areas...
NasdaqCM:AEHR
NasdaqCM:AEHRSemiconductor

Aehr Test Systems Q3 Losses And 43x P/S Test Bullish Growth Narrative

Aehr Test Systems (AEHR) has released its Q3 2026 numbers, reporting revenue of US$10.3 million and a basic EPS loss of US$0.10, alongside net income excluding extra items of a US$3.2 million loss. The company has seen quarterly revenue move between US$13.5 million and US$18.3 million since Q2 2025, while basic EPS has ranged from a profit of US$0.78 per share on a trailing twelve month basis in 2025 to a loss of US$0.38 per share over the most recent twelve month window. This keeps the focus...
NYSE:PAGS
NYSE:PAGSDiversified Financial

Is It Time To Reassess PagSeguro Digital (PAGS) After Its Sharp Five Year Share Price Drop

If you are wondering whether PagSeguro Digital's current share price truly reflects its underlying worth, this article walks through the key signals you can use to judge that. The stock recently closed at US$10.76, with returns of 2.2% over the last 7 days, 7.8% over 30 days, 11.3% year to date, 35.4% over 1 year, 31.3% over 3 years and a 75.3% decline over 5 years. Recent coverage has focused on PagSeguro Digital's position within diversified financials and how changing views on digital...
NasdaqGS:CVBF
NasdaqGS:CVBFBanks

CVB Financial Merger Approval Shifts Focus To Integration And Growth

CVB Financial received final regulatory approval for its merger with Heritage Commerce. The companies now have clearance to close the transaction, which is expected to happen imminently. The approval moves the combination from planning to full integration for customers, employees, and shareholders. For investors tracking CVB Financial, ticker NasdaqGS:CVBF, the timing of this approval comes with the stock at $20.3 and a value score of 4. Over the past year the shares have returned 20.8%,...
NasdaqGS:RPRX
NasdaqGS:RPRXPharmaceuticals

Assessing Royalty Pharma (RPRX) Valuation After Johnson & Johnson Autoimmune Co Funding Deal

Royalty Pharma (RPRX) is back in focus after announcing a US$500 million R&D co funding agreement with Johnson & Johnson to advance JNJ-4804, an investigational autoimmune therapy targeting IL-23 and TNF pathways. See our latest analysis for Royalty Pharma. The J&J co funding news lands on top of an already strong run, with Royalty Pharma’s 90 day share price return of 18.98% and 1 year total shareholder return of 51.96% suggesting momentum has been building. If this kind of deal making has...
NasdaqGS:ROCK
NasdaqGS:ROCKBuilding

Assessing Gibraltar Industries (ROCK) Valuation After Recent Share Price Swings And Renewed Business Focus

Event driven snapshot of Gibraltar Industries With no single headline event setting the tone, Gibraltar Industries (ROCK) draws attention through its recent trading performance, mixed short term and multi month returns, and value focused metrics that many investors are reassessing. See our latest analysis for Gibraltar Industries. The recent 5.35% 1-day share price return and 2.50% 7-day share price return contrast with a 90-day share price return decline of 21.39% and a 1-year total...
NasdaqGS:HTFL
NasdaqGS:HTFLHealthcare Services

Assessing HeartFlow (HTFL) Valuation After Mixed Price Performance And Rich Revenue Multiple

Event context and recent price action HeartFlow (HTFL) has attracted fresh attention after a recent uptick in its share price, building on a 0.8% gain over the past day and a 10.5% move across the past week. That short term strength sits alongside a 16.8% rise over the past month, set against a 19.1% decline across the past 3 months and a 6.5% negative return year to date. Together, these figures give investors a mixed recent picture. See our latest analysis for HeartFlow. Putting that into...
NasdaqGS:TPG
NasdaqGS:TPGCapital Markets

TPG Updates TPG Rise Team As Nadia Karkar Departs For 500 Global

Nadia Karkar has left TPG Rise to become a Managing Partner at 500 Global. She previously led global business development and TPG Rise's Global South Initiative. Her departure affects TPG's climate focused investing and relationships in emerging markets. TPG, traded as NasdaqGS:TPG, is in the spotlight after this leadership change within its impact investing arm. The shares most recently closed at $38.26, with a 3 year return of 47.4% and a 1 year return of a 13.4% decline. The stock is...
NYSE:CNK
NYSE:CNKEntertainment

The Bull Case For Cinemark Holdings (CNK) Could Change Following Record Easter Box Office And Merchandise Success

Cinemark Holdings recently reported that it achieved an all-time high five-day Easter weekend domestic box office, powered by a diverse film slate and exceptionally strong attendance led by The Super Mario Galaxy Movie. The company also delivered its best-ever merchandise program tied to the film, suggesting that immersive activations and themed food and beverage can materially boost non-ticket revenue and deepen audience engagement. We’ll now examine how this record Easter performance,...